期刊文献+

脑膜瘤的分子生物学及发病机制的研究进展 被引量:6

下载PDF
导出
摘要 脑膜瘤是成人常见的中枢系统肿瘤之一,起源于蛛网膜帽状细胞,大部分为良性,生长缓慢。其每年发病率是4.4/10万,男女比例为1∶2,但高级别脑膜瘤在男性中更常见。按照2007年世界卫生组织(WHO)肿瘤分类法将脑膜瘤分为:WHOⅠ级,包括脑膜上皮型、移行型、砂粒型、血管瘤型、微小囊型、分泌型、淋巴浆细胞丰富型和化生型;WHOⅡ级,包括非典型脑膜瘤、透明细胞型脑膜瘤、脊索样变型脑膜瘤和脑组织侵犯型脑膜瘤;WHO Ⅲ级,包括间变性/恶性脑膜瘤、横纹肌样脑膜瘤、乳头状脑膜瘤,各级别脑膜瘤占所有脑膜瘤分别约为80%、15%~20%和1%~3%。
作者 徐奖 王淳良
出处 《广东医学》 CAS CSCD 北大核心 2013年第3期473-475,共3页 Guangdong Medical Journal
基金 江西省自然科学基金资助项目(编号:20114BAB205047)
  • 相关文献

参考文献1

二级参考文献13

  • 1Shak S. Overview of the trastuzumab (Herceptin) anti-HER2 monoclonal antibody clinical program in HER2-overexpressing metastatic breast cancer. Herceptin Multinational Investigator Study Group. Semin Oncol, 1999, 26(4 Suppl 12) : 71-77. 被引量:1
  • 2Terzi A, Saglam EA, Barak A, et al. The significance of immunohistochemical expression of Ki-67, p53, p21, and p16 in meningiomas tissue arrays. Pathol Res Pract, 2008,204 (5) :305- 314. 被引量:1
  • 3Hicks DG, Tubbs RR. Assessment of the HER2 status in breast cancer by fluorescence in situ hybridization: a technical review with interpretive guidelines. Hum Pathol, 2005, 36 ( 3 ) : 250- 261. 被引量:1
  • 4Wang S, Hossein Saboorian M, et al. Aneusomy 17 in breast cancer: its role in HER-2/neu protein expression and implication for clinical assessment of HER-2/neu status. Mod Pathol, 2002, 15(2) :137-145. 被引量:1
  • 5Kleihues P, Cavenee WK. World Health Organization classification of tumours. Pathology and genetics of turnouts of the nervous system. Lyon : IARC Press, 2000. 被引量:1
  • 6Slamon D J, Godolphin W, Jones LA, et al. Studies of the HER- 2/neu proto-oncogene in human breast and ovarian cancer. Science, 1989, 244(4905): 707-712. 被引量:1
  • 7Leon-Chong J, Lordick F, Kang Y, et al. HER2 positivity in advanced gastric cancer is comparable to breast cancer. J Clin Oncol, 2007, 25:15057. 被引量:1
  • 8Loussouarn D, Brunon J, Avet-Loiseau H, et al. Prognostic value of HER2 expression in meningiomas : an immunohistochemical and fluorescence in situ hybridization study. Hum Pathol, 2006, 37 (4) :415-421. 被引量:1
  • 9Langford LA, Cooksley CS, DeMonte F. Comparison of MIB-1 (Ki-67) antigen and bromodeoxyuridine proliferation indices in meningiomas. Hum Pathol, 1996, 27(4) : 350-354. 被引量:1
  • 10Mao Y, Wu J, Wang N, et al. A comparative study: immunohistochemical detection of cytosolic thymidine kinase and proliferating cell nuclear antigen in breast cancer. Cancer Invest, 2002, 20(7-8) : 922-931. 被引量:1

共引文献5

同被引文献61

  • 1李杰,孙钢,朱仕芳,丁娟,郁冰冰,邓勇.微小脑膜瘤的MRI诊断[J].医学影像学杂志,2005,15(11):925-926. 被引量:8
  • 2王连平,王正希,夏立丰,谌南武.脑膜瘤中雌、孕激素受体表达及临床病理意义[J].中国医师杂志,2007,9(4):536-537. 被引量:2
  • 3白人驹,张雪林.医学影像诊断学[M].北京:人民卫生出版社,2011:300-328. 被引量:12
  • 4YAMASAKI F, YOSHIOKA H, l-lAMA S, et al. Recurrence of meningiomas[J]. Cancer, 2000, 89(5): 1102-1110. 被引量:1
  • 5Yamakami I, Higuchi Y, Horiguchi K, et al. Treatment poli- cy forpetroclival meningioma based on tumor size: aiming radical removal insmall tumors for obtaining cure without morbidity[J]. Neurosurg Rev,2011,34(3) : 327-334. 被引量:1
  • 6Wu QW,Yan RF,Li Q,et al. Magnetic resonance image manifestations of the atypical meningioma[J]. Asian Pac J Cancer Prev, 2013,14( 11 ) : 6337-6340. 被引量:1
  • 7Kawahara Y,Nakada M,Hayashi Y,et al. Prediction of high-grade meningioma by preoperative MRI assessment[J]. J Neuro-oncol, 2012, 108( 1 ) : 147-152. 被引量:1
  • 8Zali H, Rezaei Tavirani M. Meningioma protein-protein interaction network[ J]. Arch Iran Med, 2014,17 (4) :262-272. 被引量:1
  • 9Kasuya HI, Kubo O, Kato K, et al. Histological characteristics of incidentally-found growing meningiomas[ J]. J Med Invest, 2012, 59(3-4) :241-245. 被引量:1
  • 10Wu QW, Yan RF, Li Q, et al. Magnetic resonance image mani- festations of the atypical meningioma [ J ]. Asian Pac J Cancer Prev, 2013,14( 11 ) :6337--6340. 被引量:1

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部